CClinicalTrials.gg
Sign In
Status unknownNCT05381558Updated May 19, 2022

Evaluation of the Role of Local Steroid Injection in Treatment of Idiopathic Spasmodic Flat Foot in Adolescent Patients

An interventional study of Triamcinolone Injection in Flatfoot, sponsored by Assiut University. Status unknown at 1 site in Egypt. Open to participants aged 10 Years to 16 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-05-19.

Sponsored by Assiut University · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified May 2022), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 1 year 1 month after the study started (first participant enrolled Apr 2021, registered May 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
10 Years to 16 Years
Sex
All
01

Study summary

  • Population: adolescent patients aged from 10 to 16 years

  • Interventions:

    1. Examination under general anaesthesia if the deformity corrected spontaneously
    2. local injection of steroid in sinus tarsi
    3. cast in varus for 6 weeks
  • Outcomes: primary outcome : Evaluate the clinical and functional outcomes according AOFAS.
  • Time: follow up within one and half month, 3 months, 6 months, one year.
Read the detailed description
  • Does local steroid injection have a role in treatment of spasmodic flat foot in adolescent patients? One of the most common foot complaints in the juvenile and adolescent age group is the "flatfoot" deformity. (1) Clinical evaluation of flatfeet primarily focuses on differentiation between the two main types: flexible and rigid. (2) The flexible type is a common diagnosis and is one which is usually not problematic and rarely needs treatment. (3) Rigid flatfoot deformity is less common (occurring one-third as often as the flexible type) but often is symptomatic and requires treatment. (4) Spasmodic valgus foot is usually associated with resistant pain and deformity. It shows controversy regarding its incidence, etiology, and treatment. (5) Spasmodic flatfoot is a rare condition characterized by a rigid and usually painful valgus deformity in the hind foot with peroneal muscles spasms (6,7) It is often caused by inter-tarsal bars or bone anomalies that restrict tarsal joint motion . (8) Our study aims to evaluate the functional and clinical outcome after local long-acting steroid injection in the sinus tarsi followed by cast in adolescent patients with spasmodic flatfeet without coalition.
02

Conditions studied

  • Flatfoot

Browse trials for

03

In context

Flatfoot

168 studies on the registry are indexed under Flatfoot; 41 are open to participants now.

This study's planned enrollment of 20 is below the median of 37 across 121 interventional studies indexed under Flatfoot.

Browse Flatfoot studies →

Lead sponsor

Assiut University is the lead sponsor of 4,901 studies on the registry; 2,098 are open to participants now.

Of its 13 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 16 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age of the patients from 10 to 16 years
  • Flat foot with peroneal muscle spasm

Exclusion criteria

Exclusion Criteria:

  • Flatfoot uncorrected by manipulation under general anaesthesia

    • neuromuscular disorders
    • evidence of coalition in CT or MRI
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    spasmotic flatfoot patient

    Drug: Triamcinolone Injection

Interventions

  • DrugTriamcinolone Injection

    local injection in sinus tarsi

06

What researchers measure

Primary outcomes

  1. Evaluate the functional outcomes according AOFAS Ankle-hindfoot scale

    Time frame: 45days

07

Study locations

1 of 1 sites recruiting
  • Faculty of Medicine Assiut University
    Assiut, Egypt
    Recruiting
08

References and documents

Publications

  • BLOCKEY NJ. Peroneal spastic flat foot. J Bone Joint Surg Br. 1955 May;37-B(2):191-202. doi: 10.1302/0301-620X.37B2.191. No abstract available. PubMed 14381462 ↗
  • Jayakumar S, Cowell HR. Rigid flatfoot. Clin Orthop Relat Res. 1977 Jan-Feb;(122):77-84. PubMed 837623 ↗
  • Harris EJ, Vanore JV, Thomas JL, Kravitz SR, Mendelson SA, Mendicino RW, Silvani SH, Gassen SC; Clinical Practice Guideline Pediatric Flatfoot Panel of the American College of Foot and Ankle Surgeons. Diagnosis and treatment of pediatric flatfoot. J Foot Ankle Surg. 2004 Nov-Dec;43(6):341-73. doi: 10.1053/j.jfas.2004.09.013. No abstract available. PubMed 15605048 ↗
  • Luhmann SJ, Rich MM, Schoenecker PL. Painful idiopathic rigid flatfoot in children and adolescents. Foot Ankle Int. 2000 Jan;21(1):59-66. doi: 10.1177/107110070002100111. PubMed 10710264 ↗
  • HARRIS RI, BEATH T. Etiology of peroneal spastic flat foot. J Bone Joint Surg Br. 1948 Nov;30B(4):624-34. No abstract available. PubMed 18894612 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 19, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05381558
Lead sponsor
Assiut University
Responsible party
Pemen Phillip Adely (resident doctor, Assiut University) — Principal investigator
First posted
May 19, 2022
Start date
Apr 1, 2021
Primary completion
Sep 2022 (estimated)
Completion
Sep 2022 (estimated)
Last update
May 19, 2022

Study contacts

pemen philllip, bachelor
Contact
pemen.phillip@gmail.com
01019944221
peter phillip, bachelor
Contact
01201949869

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Flatfoot→

Other studies from this sponsor

Assiut University

Start the discussion